| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Equipe dAccueil 2941 Rayonnement Synchrotron et Recherche Médicale, Unité IRM [S. C., J. B., H. E., A. J., M-C. B., J-F. A., A-M. C., J-F. L., F. E., N. F.], Département de Cancérologie et dHématologie [J. B.], and INSERM IFR 1 [H. E.], CHU A. Michallon, BP 217, F-38043 Grenoble cedex 09, France; European Synchrotron Radiation Facility, BP 220, F-38043 Grenoble, France [M. R., T. B.]; and Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton, BN19RQ, United Kingdom [N. F.]
Combination of cis-platinum with ionizing radiation is one of the most promising anticancer treatments that appears to be more efficient than radiotherapy alone. Unlike conventional X-ray emitters, accelerators of high energy particles like synchrotrons display powerful and monochromatizable radiation that makes the induction of an Auger electron cascade in cis-platinum molecules [also called photoactivation of cis-platinum (PAT-Plat)] theoretically possible. Here, we examined the molecular consequences of one of the first attempts of synchrotron PAT-Plat, performed at the European Synchrotron Research Facility (Grenoble-France). PAT-Plat was found to result in an extra number of slowly repairable DNA double-strand breaks, inhibition of DNA-protein kinase activity, dramatic nuclear relocalization of RAD51, hyperphosphorylation of the BRCA1 protein, and activation of proto-oncogenic c-Abl tyrosine kinase.
This article has been cited by other articles:
![]() |
J. Rousseau, C. Boudou, R. F. Barth, J. Balosso, F. Esteve, and H. Elleaume Enhanced Survival and Cure of F98 Glioma Bearing Rats following Intracerebral Delivery of Carboplatin in Combination with Photon Irradiation Clin. Cancer Res., September 1, 2007; 13(17): 5195 - 5201. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Stasio, D. Rajesh, J. M. Ford, M. J. Daniels, R. J. Erhardt, B. H. Frazer, T. Tyliszczak, M. K. Gilles, R. L. Conhaim, S. P. Howard, et al. Motexafin-Gadolinium Taken Up In vitro by at Least 90% of Glioblastoma Cell Nuclei Clin. Cancer Res., January 1, 2006; 12(1): 206 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Biston, A. Joubert, J.-F. Adam, H. Elleaume, S. Bohic, A.-M. Charvet, F. Esteve, N. Foray, and J. Balosso Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis-Platinum and Irradiated with Monochromatic Synchrotron X-Rays Cancer Res., April 1, 2004; 64(7): 2317 - 2323. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |